Work

A phase I trial of pomalidomide in combination with liposomal doxorubicin in patients with Kaposi sarcoma with or without other KSHV-associated diseases.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.11552

Authors: Ramya Ramaswami, Kathryn Anne Lurain, Anaida Widell, Priscila Hermont Goncalves, Irene Ekwede, William Douglas Figg, Cody J. Peer, Ralph Mangusan, Jomy George, Seth M. Steinberg, Vikram Khetani, Denise Whitby, Thomas S. Uldrick, Robert Yarchoan

Institutions: National Cancer Institute, Center for Cancer Research, National Institutes of Health, National Institutes of Health Clinical Center, Celgene (United States), Frederick National Laboratory for Cancer Research

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3031013740

Cites:

Cited by: 7

Related to: 10